Assessing the burden of osteoarthritis in Latin America: a rapid evidence assessment

This rapid evidence assessment (REA) was conducted to explore the burden of weight-bearing joint osteoarthritis in the developing countries of Latin America. REA methodology used a standardized search strategy to identify observational studies published from 2010 to 23 April 2020 that reported outcomes pertaining to the epidemiology and humanistic or economic burden of weight-bearing osteoarthritis. Relevant data from each included study were used to populate bespoke data extraction tables and qualitatively analyzed. Thirteen publications were identified that reported on knee and hip osteoarthritis in the Latin American region. Overall prevalence of physician-diagnosed symptomatic knee osteoarthritis in adults ranged from 1.55% in Peru to 7.4% in Ecuador. Total prevalence of grade ≥ 2 radiographic knee osteoarthritis was 22% among those ≥ 39 years of age in Brazil and 25.5% among those ≥ 40 years of age in Mexico. The prevalence of symptomatic/radiographic knee osteoarthritis was 7.1% in people ≥ 18 years of age in Mexico and 17.6% among those ≥ 40 years of age. Prevalence of hip osteoarthritis was similar to or slightly lower than knee osteoarthritis. The limited data available indicates weight-bearing osteoarthritis negatively affects quality of life and that the economic burden may vary between countries with different healthcare systems. The limited evidence found in the published literature suggests the burden of osteoarthritis in Latin America is substantial. Our analysis identified several evidence gaps, particularly for health-related quality of life and socioeconomic outcomes. Further research is of particular importance in areas where government-subsidized healthcare and resources are scarce.Fil: de Andrade, Daniel Ciampi. Hospital das Clínicas; BrasilFil: de Andrade, Daniel Ciampi. Aalborg University. Department of Health Science and Technology. Center for Neuroplasticity and Pain; DinamarcaFil: de Andrade, Daniel Ciampi. Universidade de São Paulo. Faculdade de Medicina. Pain Center. LIM‑62; BrasilFil: Saaibi, Diego. Universidad Autonoma de Bucaramanga; ColombiaFil: Sarría, Nicolas. Universidad Católica de Córdoba; ArgentinaFil: Sarría, Nicolas. Instituto Oulton; ArgentinaFil: Ruiz, Leslie Cano. Pfizer; ArgentinaFil: Espinosa, Rolando. National Institute of Rehabilitation. Rheumatology Department; MéxicoFil: Vainstein, Nora. Pfizer; Argentin